Cargando…
In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting
Ischemic cardiac disease (ICD) is a cardiovascular disease with high morbidity and mortality. In this study, a novel myocardial targeted drug delivery system was developed represented by co-modified liposomes consisting of red cell membrane (RCM), and the peptides TAT and PCM. Liposomes were prepare...
Autores principales: | Liu, Xueyan, Zhang, Liangke, Jiang, Wengao, Yang, Zhangyou, Gan, Zongjie, Yu, Chao, Tao, Ran, Chen, Huali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191910/ https://www.ncbi.nlm.nih.gov/pubmed/32308051 http://dx.doi.org/10.1080/10717544.2020.1754525 |
Ejemplares similares
-
PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations
por: Wang, Xin, et al.
Publicado: (2017) -
Rhodotorula glutinis as a living cell liposome to deliver polypeptide drugs in vivo
por: Fei, Zhengbin, et al.
Publicado: (2019) -
Metal-free and solvent-free synthesis of m-terphenyls through tandem cyclocondensation of aryl methyl ketones with triethyl orthoformate
por: Xiao, Xiaoqin, et al.
Publicado: (2020) -
Liposomes co-delivery system of doxorubicin and astragaloside IV co-modified by folate ligand and octa-arginine polypeptide for anti-breast cancer
por: Yue, Guijuan, et al.
Publicado: (2020) -
Drug Delivery via Cell Membrane Fusion Using Lipopeptide
Modified Liposomes
por: Yang, Jian, et al.
Publicado: (2016)